A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
for Atopic Dermatitis (AD)
48 locations incl. Phoenix
Sponsor: Bluefin Biomedicine, Inc.
Sex: All·Age: 18 - 75
Code: NCT07105488·Phase 2·Recruiting·Listed Aug 2025
Skin Cancer and Dermatology Institute
Clinical research site in Douglasville, Georgia · 4645 TIMBER RIDGE DR, SUITE 100, DOUGLASVILLE, GA 30135-7541 · (678) 702-3376
Part of Skin Cancer and Dermatology Institute
As of July 2026, 2 paid clinical trials are recruiting at Skin Cancer and Dermatology Institute in Douglasville, Georgia. Active studies at this site focus on Atopic Dermatitis (AD) alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Skin Cancer and Dermatology Institute (2)
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for Chronic Spontaneous Urticaria (CSU)
128 locations incl. Birmingham
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06868212·Phase 3·Recruiting·Listed Mar 2025
More research sites in Douglasville
- Woolfson Eye Institute (2 trials)
- Alliance Spine and Pain Ctrs (1 trial)
- American Clinical Trials (1 trial)
- American Clinical Trials LLC - Douglasville (1 trial)
- LEO Pharma Investigational Site (1 trial)
- Local Institution - 007-786-D (1 trial)
- Southeast Dermatology Specialists (1 trial)
- Southeast Research Specialist LLC (1 trial)
- Southeast Research Specialists (1 trial)
- Southeast Research Specialists, LLC (1 trial)
Explore more
Paid clinical trials in Douglasville, GA · Georgia clinical trials